Laboratories submitting samples from suspected or confirmed mpox cases to the NVRL for testing must:

• Indicate the requirement for mpox testing on the external packaging
• Ensure that all samples – including both mpox diagnostic swabs and other sample types – are clearly marked as “probable (or confirmed) mpox”

For detailed sampling, packaging and transport requirements, please refer to the NVRL User Manual and current national guidelines – Laboratory Testing in Patients with confirmed or clinically suspected mpox (V 4.5, published 18/03/2026)

If you have any queries, please contact NVRL Clinical team on 01-7164401, and select option 2.

CN-26-8